Featured Research

from universities, journals, and other organizations

Cardiovascular disease risk of high normal blood pressure decreases in old age

Date:
April 20, 2012
Source:
World Heart Federation
Summary:
High normal blood pressure becomes less of a risk factor for incident cardiovascular disease and coronary heart disease with age, according to a new study.

High normal blood pressure becomes less of a risk factor for incident cardiovascular disease (CVD) and coronary heart disease (CHD) with age, according to a new study presented April 20 at the World Congress of Cardiology.

The study, carried out over 9.3 years, evaluated the risk of different blood pressure categories among 6,273 participants aged 30 years old and above. The results showed that the risk of developing incident CVD and CHD was significantly higher in people with high normal blood pressure during middle-age (between 30 and 60 years of age) than for people with the same high normal blood pressure aged 60 years and older. Incident CVD and CHD risk was, however, similarly high in people with diagnosed high blood pressure across all age-groups.

"These results reinforce the fact that high blood pressure is a serious risk for CVD in all age groups," said Dr. F. Hadaegh, Prevention of Metabolic Disorders Research Center, Tehran, Iran. "However, the results also suggest that when looking to manage high normal blood pressure resources should be focused on those individuals that are in middle age."

High blood pressure is defined as a repeatedly elevated systolic pressure of 140 mmHg or higher OR a diastolic pressure of 90 mmHg or higher. This study was carried out over 9.3 years and the study protocol established before new guidelines around high normal blood pressure were adapted. In 2003, the Joint National Committee 7(JNC7) from the United States introduced the concept of prehypertension into guidelines categorizing the individuals with systolic blood pressure between 120-139 mmHg or diastolic blood pressure between 80-89 as prehypertension groups.


Story Source:

The above story is based on materials provided by World Heart Federation. Note: Materials may be edited for content and length.


Cite This Page:

World Heart Federation. "Cardiovascular disease risk of high normal blood pressure decreases in old age." ScienceDaily. ScienceDaily, 20 April 2012. <www.sciencedaily.com/releases/2012/04/120420105719.htm>.
World Heart Federation. (2012, April 20). Cardiovascular disease risk of high normal blood pressure decreases in old age. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/04/120420105719.htm
World Heart Federation. "Cardiovascular disease risk of high normal blood pressure decreases in old age." ScienceDaily. www.sciencedaily.com/releases/2012/04/120420105719.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins